VC  MS Ventures

http://www.ms-ventures.com/en/index.html





     Office Locations:

One Technology Place
Rockland, MA 02370

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    MS Ventures is the corporate venture arm of the biopharmaceutical division of Merck KGaA. The firm seeks to invest globally in early-stage biotechnology companies. Along with EUR 100 million through the MS Ventures fund, MS Ventures also manages the EUR 30 million Entrepreneur Partnership Program fund. This program was established to support the creation of spin-offs and the EUR 10 million Israel Bioincubator Fund, focused on pre-seed and seed opportunities coming out of Israel.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alicia Irurzun-Lafitte
    Edward Kliphuis
    Hakan Goker PhD
    Jasper Bos PhD
    Nilesh Kumar

     

    Portfolio companies include:


      Ambrx
        web link


      Asceneuron
        web link


      Auxogyn
        web link


      Calypso Biotech
        web link


      Canbex Therapeutics
        web link


      EpiTherapeutics
        web link


      f-star
        web link


      Forendo Therapeutics
        web link


      Galecto Biotech
        web link


      Padlock Therapeutics
        web link


      Prexton Therapeutics
        web link


      Raze Therapeutics
        web link


     

    Recent News: